We present a literature review of collaborative enterprises between psychiatrists and primary care physicians in Israel and other countries. Also described are local psychiatric liaison initiatives in Israel, as well as landmark studies of collaborative psychiatric care. These studies demonstrate the superiority of community psychiatric liaison models in the treatment of patients suffering from depressive anxiety disorders and somatization disorder. In light of the mental health reform process currently underway in Israel, it is important to develop, implement and assess such liaison models.

Download full-text PDF

Source

Publication Analysis

Top Keywords

psychiatric liaison
8
liaison models
8
psychiatric
4
psychiatric collaboration
4
collaboration models
4
israel
4
models israel
4
israel literature
4
literature review
4
review collaborative
4

Similar Publications

Clinical Utility and Performance of the Traditional Chinese Version of the 4-As Test for Delirium Due to Traumatic Brain Injury.

J Acad Consult Liaison Psychiatry

January 2025

School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan; Department of Nursing, Taipei Medical University Hospital, Taipei, Taiwan. Electronic address:

Background: Delirium is a common symptom following a traumatic brain injury (TBI) that is often overlooked by healthcare professionals. Early detection of post-traumatic delirium is crucial to improving patient outcomes and quality of life. The four As Test (4AT: alertness, attention, abbreviated mental test-4, and acute mental changes) is a brief and rapid tool for delirium assessment with acceptable reliability and validity.

View Article and Find Full Text PDF

Medical contraindications and complications pose challenges for electroconvulsive therapy (ECT). Most published reports are scattered across various physiological systems and individual disease conditions. This review aimed to evaluate the literature on physiological and medical complexities during ECT and discuss risk mitigation strategies in a comprehensive review.

View Article and Find Full Text PDF

Bromocriptine for Residual Catatonia Following Neuroleptic Malignant Syndrome: Illustrative Case Report and Systematic Review.

J Acad Consult Liaison Psychiatry

January 2025

Department of Psychiatry and Behavioral Neurosciences, University of South Florida, Tampa, FL, USA, 33613; Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL, 32608.

Background: Neuroleptic malignant syndrome (NMS) is a rare yet potentially fatal iatrogenic syndrome that can manifest with life-threatening symptoms. Theorized to be caused by the dopamine-blocking effects of certain medications, such as antipsychotics, or the withdrawal of dopaminergic agents, NMS is characterized by hyperthermia, autonomic instability, altered mental status, and muscular rigidity. Most treated cases resolve within weeks; however, in some cases, residual catatonic symptoms can persist for months after the resolution of acute hyperthermic and hypermetabolic symptoms.

View Article and Find Full Text PDF

Dexmedetomidine in the ICU for Extreme Aggression in a Child with Catatonia.

J Acad Consult Liaison Psychiatry

January 2025

Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences; Vanderbilt University Medical Center at Village of Vanderbilt, 1500 21st Avenue South, Suite 2200, Nashville, Tennessee, 37212; Vanderbilt Kennedy Center, Vanderbilt University; 110 Magnolia Circle, Nashville, TN, 37203.

View Article and Find Full Text PDF

How can I better recognize and manage delirium in my hospitalized patients?

Cleve Clin J Med

January 2025

Attending Physician, UPMC Mercy Consultation-Liaison Psychiatry Service, Pittsburgh, PA; Assistant Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!